InnovAge: Selling shareholder sells 10 million shares in underwritten offering at $9.25
InnovAge disclosed an underwriting agreement dated September 22, 2026, under which a selling shareholder agreed to sell 10,000,000 shares of common stock at $9.25 per share through underwriters including Barclays, Goldman Sachs and Wells Fargo. The company says it will receive no proceeds, and shares were delivered on September 24, 2026. The sale is by an existing shareholder rather than new company capital, so it affects share supply and ownership rather than the company's own funding.
Key points
- Selling shareholder agreed to sell 10,000,000 shares at $9.25 per share to the underwriters
- Underwriters have a 30-day option, from September 22, 2026, to buy up to an additional 1,500,000 shares
- InnovAge will not receive any proceeds from the sale of the shares
- Shares were delivered against payment on September 24, 2026
The filing
Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 24, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.